Pfizer (PFE) Misses Q3 EPS by 9c; Reaffirms FY Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.11 +0.64%
EPS Growth %: -12.6%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -12.6%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $13.33 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $1.45-$1.65, versus the consensus of $1.50. Pfizer sees FY2023 revenue of $58-61 billion, versus the consensus of $55.37 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- General Mills (GIS) Tops Q1 EPS by 3c
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
